Stay updated on Pembrolizumab in Untreated Extensive SCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Untreated Extensive SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Untreated Extensive SCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added the keyword 'Small cell lung carcinoma' and a new 'resources' section linking to the Genetic and Rare Diseases Information Center.
    Difference
    0.1%
    Check dated 2026-04-02T06:17:08.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision history updated to include v3.5.0 and remove v3.4.3. This is a minor metadata update that does not affect study content or results.
    Difference
    0.0%
    Check dated 2026-03-18T20:29:27.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision: v3.4.3 added in the page header, replacing Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T18:49:04.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2, and a government funding/operating status notice and the earlier Revision: v3.4.1 were removed; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T10:20:52.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding lapse and NIH operating status. Updated the page to version v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:13:30.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Minor UI and metadata updates: glossary display option added and footer text updated to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', replacing the previous labels.
    Difference
    0.2%
    Check dated 2026-01-28T04:48:42.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Untreated Extensive SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Untreated Extensive SCLC Clinical Trial page.